Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets

NCT07681544 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Empirical Antimicrobial Therapy
Critically Ill
Meropenem
Pharmacokinetics and Pharmacodynamics

Interventions

DIAGNOSTIC_TEST: Blood extraction

Sponsor

Hospital Italiano de Buenos Aires